New pain block could cut opioid use after cancer surgery
NCT ID NCT07263165
First seen Jan 06, 2026 · Last updated Apr 24, 2026 · Updated 16 times
Summary
This study tests whether adding dexmedetomidine to a standard numbing medicine (bupivacaine) can improve pain control after upper abdominal cancer surgery. About 54 adults undergoing surgeries like stomach or liver removal will receive an ultrasound-guided nerve block. The goal is to reduce the need for opioid painkillers in the first 24 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID CONSUMPTION, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.